2Macaulay VM. Insulin-like growth factors and cancer [J]. Br J Cancer, 1992, 65(3): 311～320
3Stein CA, Cheng YC. Antisense oligoncleotides as theropeutic agents as the bullet really magical [J]. Science, 1993, 261 (5124):1004～1012
4PriceJA, Kovach SJ, Johnson T, et al. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma[J]. Hepatology, 2002, 36(5): 1089 ～ 1097
5Ellouk-Achard S, Djenabi S, De Oliveira GA, et al. Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF- Ⅰ antisense c-DNA[J].J Hepatol, 1998, 29(5):807～818
6Bravo R, Frank R, Blundell PA. Cyclin/PCNA is the auxiliary protein of DNA polymerase delta [J]. Nature, 1987, 326 (6112):515～517
7Matturri L, Colimbo B, Lavezzi AM. Evidence for apoptosis in non-small cell lung carcinoma,relationship with cell kinetics and progress[J]. Anel Quant Cytol Histol, 1999, 21:240～244
8Domen J, Weissman IL. Hematopoietic stem cells and other hematopoietic cells show broad resistance to chemotherapeutic agents in vivo when overexpressing bcl-2. Exp Hematol, 2003,31:631-639.
9Raisova M, Hossini AM, Eberle J, et al. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol, 2001,117: 333-340.
10Ravi R, Bedi A. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res, 2002, 62:1583-1587.
